Yahoo Finance

NuVasive's (NUVA) PRECICE System Gets Expanded FDA Approval

NuVasive, Inc. NUVA has been in the news of late for the receipt of expanded FDA 510(k) approval for its advanced magnetic and non-invasive limb lengthening technology — PRECICE. Falling under ...
Nasdaq

NuVasive Specialized Orthopedics Reaches 10,000 Nail Implant Milestone of the Precice® System for Limb Lengthening

SAN DIEGO, Aug. 14, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally ...
Healio

FDA issues update on biocompatibility concerns with NuVasive Precice devices

Please provide your email address to receive an email when new articles are posted on . The FDA has issued a letter to health care providers with updated recommendations for the use of NuVasive ...
Healio

NuVasive receives FDA 510(k) clearance for limb lengthening system in pediatric patients

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. NuVasive received FDA clearance of its limb lengthening ...
Stockhouse

NuVasive Expands Precice Portfolio with First-of-its-Kind Plate for Pediatric Limb Lengthening and Reconstruction Procedures

SAN DIEGO, Sept. 9, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally ...
Yahoo Finance

NuVasive's (NUVA) Precice System Cleared for Pediatric Patients

NuVasive NUVA recently obtained FDA’s 510(k) clearance for its Precice system to be used for treatment of pediatric patients. The all-internal limb lengthening solution belongs to the company’s ...
WGN-TV

NuVasive Specialized Orthopedics Surpasses 100 Peer-Reviewed Publications of the Precice System for Limb Lengthening

SAN DIEGO, April 26, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA) today announced a milestone of more than 100 peer-reviewed publications of the Precice ® System (Precice) for conditions related ...

GMED Growth Drivers After NuVasive and What Q1 Signals

Globus Medical's Q1 showed margin gains, strong spine and trauma growth, and rising robotics adoption as NuVasive synergies support 2026 targets.
Stockhouse

NuVasive Specialized Orthopedics Expands Indications of Precice Limb Lengthening System to Treat Pediatric Patients

SAN DIEGO, March 20, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally ...